With newest drug approval for Gaucher, Genzyme returns to its beginnings

The U.S. approval of Genzyme's first-ever pill for Gaucher disease caps a 30-year history in which one of the rarest of rare diseases has helped shape not only the iconic biotech firm, but the entire biotech industry...